We are live on
!
Find out more
Group One Trading Portfolio holdings
AUM
$52.2B
1-Year Est. Return
104.56%
This Fund
S&P 500
This Quarter
Est. Return
+9.94%
1 Year Est. Return
+104.56%
3 Year Est. Return
+314.05%
5 Year Est. Return
+338.55%
10 Year Est. Return
+1,999.92%
AUM
$43B
AUM Growth
-$7.89B
(-16%)
Cap. Flow
-$3.97B
Cap. Flow
% of AUM
-9.24%
Top 10 Holdings %
Top 10 Hldgs %
21.79%
Holding
8,577
New
1,058
Increased
2,469
Reduced
3,270
Closed
1,444
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$158M |
| 2 |
Microsoft
MSFT
|
+$62.9M |
| 3 |
Meta Platforms (Facebook)
META
|
+$55.8M |
| 4 |
Boeing
BA
|
+$34.1M |
| 5 |
ARK Innovation ETF
ARKK
|
+$29.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$128M |
| 2 |
NVIDIA
NVDA
|
+$89M |
| 3 |
Apple
AAPL
|
+$86.7M |
| 4 |
Advanced Micro Devices
AMD
|
+$47.6M |
| 5 |
Biogen
BIIB
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.37% |
| 2 | Healthcare | 1.33% |
| 3 | Consumer Discretionary | 0.84% |
| 4 | Energy | 0.65% |
| 5 | Financials | 0.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4226
PUT
Emergent Biosolutions
EBS
$230M
| $126K | ﹤0.01% |
10,700
-8,500
| -44% | -$132K |
|
4227
PUT
Build-A-Bear
BBW
$474M
| $126K | ﹤0.01% |
5,300
+1,800
| +51% | +$34.7K |
|
4228
Clene
CLNN
$53.5M
| $126K | ﹤0.01% |
+6,317
| New | +$147K |
|
4229
PUT
Leidos
LDOS
$17.9B
| $126K | ﹤0.01% |
1,200
| – | – |
|
|
BLUE
4230
PUT
DELISTED
bluebird bio
BLUE
| $126K | ﹤0.01% |
910
-8,640
| -90% | -$1.22M |
|
|
PTRA
4231
CALL
DELISTED
Proterra Inc. Common Stock
PTRA
| $126K | ﹤0.01% |
33,400
-92,200
| -73% | -$488K |
|
4232
SiTime
SITM
$20.7B
| $126K | ﹤0.01% |
+1,235
| New | +$117K |
|
4233
CALL
Oscar Health
OSCR
$9.5B
| $125K | ﹤0.01% |
51,000
-30,600
| -38% | -$95.7K |
|
|
ETNB
4234
DELISTED
89bio
ETNB
| $125K | ﹤0.01% |
9,841
+9,441
| +2,360% | +$84.9K |
|
4235
CALL
Century Communities
CCS
$2.04B
| $125K | ﹤0.01% |
2,500
-900
| -26% | -$42.6K |
|
4236
CoinShares ETF Trust CoinShares Bitcoin and Ether ETF
BTF
$13.6M
| $125K | ﹤0.01% |
3,782
-454
| -11% | -$15.9K |
|
4237
PUT
Fomento Económico Mexicano
FMX
$39.7B
| $125K | ﹤0.01% |
1,600
+400
| +33% | +$29.4K |
|
|
ISUN
4238
CALL
DELISTED
iSun, Inc. Common Stock
ISUN
| $125K | ﹤0.01% |
93,900
-30,000
| -24% | -$55.3K |
|
4239
CALL
AEye
LIDR
$59.5M
| $125K | ﹤0.01% |
8,647
-1,786
| -17% | -$46.3K |
|
4240
CALL
Tarsus Pharmaceuticals
TARS
$3.02B
| $125K | ﹤0.01% |
+8,500
| New | +$141K |
|
|
SKYT
4241
PUT
DELISTED
SkyWater Technology
SKYT
| $124K | ﹤0.01% |
17,500
+13,200
| +307% | +$112K |
|
|
AZEK
4242
DELISTED
The AZEK Co
AZEK
| $124K | ﹤0.01% |
6,123
+2,204
| +56% | +$40.8K |
|
4243
CALL
ABM Industries
ABM
$2.82B
| $124K | ﹤0.01% |
2,800
+2,700
| +2,700% | +$119K |
|
|
SOND
4244
CALL
DELISTED
Sonder
SOND
| $124K | ﹤0.01% |
5,015
-21,560
| -81% | -$762K |
|
|
ZYXI
4245
DELISTED
Zynex
ZYXI
| $124K | ﹤0.01% |
8,937
+5,508
| +161% | +$66.6K |
|
4246
PUT
Zymeworks
ZYME
$1.83B
| $124K | ﹤0.01% |
+15,800
| New | +$111K |
|
4247
PUT
Acadia Pharmaceuticals
ACAD
$4.89B
| $124K | ﹤0.01% |
7,800
-9,800
| -56% | -$153K |
|
4248
Aterian
ATER
$5.26M
| $124K | ﹤0.01% |
13,433
+2,024
| +18% | +$25.4K |
|
4249
PUT
Brookfield Infrastructure Partners
BIP
$18.4B
| $124K | ﹤0.01% |
+4,000
| New | +$140K |
|
4250
PUT
Terex
TEX
$7.57B
| $124K | ﹤0.01% |
2,900
+900
| +45% | +$36.2K |
|
Similar funds
SCP
RIM
Group One Trading's Q4 2022 Portfolio in Review
As of Q4 2022, Group One Trading held 8,577 positions worth $43B, down 16% from $50.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Group One Trading withdrew a net $3.97B in Q4 2022, closing 1,444 positions and reducing 3,270 holdings. Its most notable exit was Biogen, an estimated $30.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.4% of assets, down from 1.5% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Group One Trading opened a new position in Cigna worth $165M.
- Group One Trading's largest Q4 2022 buy was Cigna: 497,989 shares worth $165M.
- Group One Trading added most to Microsoft in Q4 2022, an estimated $62.9M increase.
- Group One Trading's biggest Q4 2022 reduction was Tesla, cutting an estimated $128M.
- Group One Trading fully exited Biogen in Q4 2022, selling an estimated $30.6M.
- Group One Trading's ten largest holdings make up 22% of its $43B portfolio in Q4 2022.
- Group One Trading opened 1,058 new positions and closed 1,444 in Q4 2022.
- Group One Trading's portfolio value fell 16% quarter-over-quarter to $43B.
Based on Group One Trading's 13F filing for Q4 2022, filed 9 Feb 2023.